ARCHIVES

PV-10 Produces 51 Percent Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Ashworth Named Center Director at UCSF

March 21, 2014

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

Letter From Congress Prompts NCI To Pull Abortion Fact Sheet From Web

July 12, 2002

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

September 9, 2011